Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: February 2022
-
By Kevin E. Noonan — In an 82-page decision, the Patent Trial and Appeal Board granted priority for eukaryotic CRISPR to the Broad Institute, Harvard University, and MIT (collectively, "Broad") as Senior Party and against Junior Party the University of California/Berkeley, the University of Vienna, and Emmanuelle Charpentier (collectively, "CVC") (the Decision on Priority 37…
-
The American Bar Association (ABA) Standing Committee on Ethics and Professional Responsibility will be offering a live webinar entitled "Ethics and Professional Responsibility: How to Comply with ABA's New Language Access Guidance" from 2:00 pm to 3:00 pm on February 28, 2022. Deepika Ravi and Hilary Gerzhoy of Harris, Wiltshire & Grannis LLP will discuss…
-
J A Kemp will be offering a webinar entitled "How and When to Prepare for the Arrival of the Unitary Patent" on March 1, 2022 from 4:00 pm to 5:00 pm (GMT). Martin Jackson and Stephen Hodsdon of J A Kemp will explain the changes from the introduction of the Unitary Patent and set out a timetable for…
-
IPWatchdog and Barash Law will be offering a webinar entitled "Pharmaceutical Salts and Other Complexes — A Solid Form Strategy" on March 1, 2022 at 12:00 pm (ET). Eyal Brash of Barash Law LLC and Gene Quinn of IPWatchdog, Inc. will discuss the patentability of solid-form salts and their use in industry, and explore novelty,…
-
Strafford will be offering a webinar entitled "Patent Drafting for Machine Learning: Claim Strategy, Patent Eligibility, and Disclosure Requirements for the U.S. and Europe" on March 1, 2022 from 1:00 to 2:30 pm (EST). Peter Arrowsmith of Gill Jennings & Every, Michael S. Borella of McDonnell Boehnen Hulbert & Berghoff, and Linda J. Thayer of…
-
By Kevin E. Noonan — In a crowded pharmaceutical art, the deficiencies thereof being so patent that the FDA encouraged industry to address and correct them, concerning a formulation developed to address the opioid crisis raging earlier in this century (see "Empire of Pain"), when is a resulting formulation obvious over that prior art and…
-
By Donald Zuhn –- Last month, the U.S. Patent and Trademark Office released its Performance and Accountability Report for Fiscal Year 2021 (FY 2021). The Report notes that in 2018 the Office issued its 2018-2022 Strategic Plan, which "outlines the framework that enables the USPTO to respond to domestic and international customers' demands for vital…
-
By Kevin E. Noonan — On December 3rd, Senior Party Sigma-Aldrich filed its Substantive Preliminary Motion No. 2 in Interference No. 106,133 (which names the Broad Institute, Harvard University, and MIT (collectively, Broad) as Junior Party), asking the Patent Trial and Appeal Board to remove Broad's U.S. Application No. 15/330,876 from the interference, pursuant to…
-
February 22, 2022 – "Update on Plausibility" (J A Kemp) – 4:00 pm to 5:00 pm (GMT) February 24, 2022 – "Biopharma Patents in China: Litigation, Licensing, and Patent Linkage" (U.S. Patent and Trademark Office) – 9:30 am to 11:00 am (ET) February 24, 2022 - "Damage Calculations in Patent Infringement Cases in the United…
-
The U.S. Patent and Trademark Office will offer a webinar entitled "Biopharma Patents in China: Litigation, Licensing, and Patent Linkage" on February 24, 2022 from 9:30 am to 11:00 am (ET). The webinar will feature presentations by senior U.S. Patent and Trademark Office IP attorneys and seasoned practitioners with extensive China IP experience. Topics to…
Patent Docs 